Renal dysfunction in symptomatic Waldenstr&#xf6;m macroglobulinaemia: A nationwide Italian multicentre study

Lymphoma

Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre

Br J Haematol

Gavriatopoulou M, Ntanasis-Stathopoulos I, Malandrakis P, Filippatos C, Spiliopoulou V, Migkou M, Theodorakakou F, Kanellias N, Eleutherakis-Papaiakovou E, Fotiou D, Katodritou E, Spanoudakis E, Tsirigotis P, Giannakoulas N, Delimpasi S, Terpos E, Dimopoulos MA, Kastritis E

doi: 10.1111/bjh.70342

Non-Malignant Blood Disorders

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study

Br J Haematol

Lucchini E, Vianelli N, Consoli U, Carli G, Carrai V, Carpenedo M, De Stefano V, Gaidano G, Palandri F, Auteri G, Rossi E, Patriarca A, Innao V, Marchesini G, Ballerini M, Rossetti MC, Mosini G, Sciancalepore P, Agnelli Giacchello J, Musto P, Rivolti E, Soverini G, Borchiellini A, Clissa C, Pane F, Galimberti S, Pavone V, Poloni A, Buccisano F, Musso M, Fazi P, Paoloni F, Gorreo Renzulli L, Zaja F

doi: 10.1111/bjh.70069

Lymphoma

Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications

Am J Hematol

Guijosa A, Tsakamaklis N, Kobs M, Kofides A, Budano N, Nguyen J, Eurell A, Meid K, Guerrera ML, Hunter ZR, Treon SP, Sarosiek S, Castillo JJ

doi: 10.1002/ajh.70269

Lymphoma

Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study

Lancet Haematol

Efficace F, Zinzani PL, Bonifazi F, Cutini I, Botto B, Chiappella A, Tisi MC, Bramanti S, Puglia S, Tartaglia F, Donzelli L, Farina M, Martino M, Gambella M, Ragaini S, Orciuolo E, Martelli M, Corradini P, Fazi P, Vignetti M, Rocco AD

doi: 10.1016/S2352-3026(26)00128-6

Lung, Respiratory and Thoracic Cancer

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database

Lung Cancer

Leuzzi G, Sabia F, Proto C, Lo Russo G, Ganzinelli M, Ferrari M, Perrino M, Cordua N, Checchi L, De Vincenzo F, Federico A, Zucali P, Lucchi M, Ambrogi MC, Aprile V, Mendogni P, Rosso L, Cecere FL, Comacchio G, Bianco R, Paolo Di Pietro M, Fabbri A, Petrini I, Trama A, De Pas TM, Conforti F, Galli G, Ruffini E, Garassino MC, Franceschini D, Berardi R, Pasello G, Solli P, TYME GROUP

doi: 10.1016/j.lungcan.2025.108871

Genitourinary Cancer

Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)

Int J Cancer

Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M

doi: 10.1002/ijc.70228

Endocrine and Neuroendocrine Tumors (NET)

Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study

Lancet Oncol

Xing M, Lin S, Mathur A, Li Y, Bendlova B, Kuklikova V, Melo M, Jesus TT, Soares P, Colombo C, Fugazzola L, Mitsutake N, Matsuse M, Sako A, Estrada-Florez AP, Carvajal-Carmona LG, Bohórquez ME, Mian C, Vianello F, O'Neill CJ, Clifton-Bligh R, Czarniecka A, Jarzab B, Jung CK, Brahma B, Ladenson PW, Park YJ

doi: 10.1016/S1470-2045(25)00399-7

Lymphoma

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study

Eur J Cancer

Fabbri N, Casadei B, Chiappella A, Stella F, Donzelli L, Galli E, Riva M, Martino M, Barbui AM, Musso M, Farina M, Angelillo P, Cutini I, Santoro A, Cavallo F, Rivela P, Castellino A, Krampera M, Petruzzellis G, Grillo G, Argnani L, Bonifazi F, Corradini P, Zinzani PL

doi: 10.1016/j.ejca.2026.116879

Genitourinary Cancer

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

Int J Cancer

Şahin G, Tüzün EK, Güzel HG, Guliyev M, Dişli AK, Yazıcı M, Yıldız O, Güneş TK, Alkan S, Kahraman EG, Özel GS, İçli MC, Şahin E, Muğlu H, Acar C, Tunbekici S, Yüksel HÇ, Yücel H, Kahya BU, Kitaplı S, Büyükşimşek M, İpek ŞA, Dama PE, Usta EA, Yılmaz M, Aşık E, Özalp FR, Savsar MG, Kocaaslan E, Sim S, Ağaoğlu AB, Çamöz ES, Demir T, Uyar GC, Yıldırım A, Çınkır HY, Salim DK, Doğu GG, Alan Ö, Bayram E, Karaçin C, Güç ZG, Ekinci F, Eryılmaz MK, Semiz HS, Ünal OÜ, Göksu SS, Öztürk B, İnanç M, Uygun K, Hacıbekiroğlu İ, Erçolak V, Kara İO, Yazıcı O, Bilici A, Tanrıverdi Ö, Karaca B, Erman M, Gökmen E, Göker E, Yıldırım HÇ

doi: 10.1002/ijc.70165

Oncology · Hematology

Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study

Related content

Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre

Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study

Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications

Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study

Treatment response after induction therapy in advanced thymic tumors: results from the Italian nationwide TYME database

Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)

Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group